You are here

Article info

Article menu

Download PDFPDF

Review
Immunological configuration of ovarian carcinoma: features and impact on disease outcome

Authors

  • Jitka Fucikova Sotio Biotech, Prague, Czech RepublicDepartment of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • An Coosemans Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, Leuven Cancer Institute, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Sandra Orsulic UCLA David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • David Cibula Gynecologic Oncology Center, Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Ignace Vergote Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University Hospital Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Lorenzo Galluzzi Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USASandra and Edward Meyer Cancer Center, New York, NY, USACaryl and Israel Englander Institute for Precision Medicine, New York, NY, USA PubMed articlesGoogle scholar articles
  • Radek Spisek Sotio Biotech, Prague, Czech RepublicDepartment of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jitka Fucikova; fucikova{at}sotio.com
View Full Text

Citation

Fucikova J, Coosemans A, Orsulic S, et al
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Journal for ImmunoTherapy of Cancer 2021;9:e002873. doi: 10.1136/jitc-2021-002873

Publication history

  • Accepted September 9, 2021
  • First published October 13, 2021.
Online issue publication 
June 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.